Service Corporation International (SCI) UBS Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
UBS Global Healthcare Conference summary
10 Nov, 2026Year-to-date performance and outlook
FY26 began with a $4.20 adjusted EPS midpoint; Q1 funeral volume fell 6% YoY amid a strong Q1 2025 flu-season comparison and a light Q1 2026 season, implying a 1.5%-2% full-year volume decline.
Q2 volume fell 1.5% versus an expected 3% decline; Q3 volume fell 0.1% versus an expected 0.5% increase.
Weaker-than-expected Q4 volume, sustained selling and advertising costs, higher fuel and healthcare costs, and negative trust returns in September led to a revised FY26 adjusted EPS midpoint of ~$4.
High-cost healthcare claims above $250,000 rose from 1-2 per month in the first five months of 2026 to 6-9 per month in June-September; the expense trend was expected to continue into Q4 and subside next year.
Growth outlook and operating trends
The normalized growth framework remains 5%-7% organic growth plus 3%-5% from capital deployment, supporting an 8%-12% adjusted EPS growth target; 2027 expectations remain under development.
2027 growth drivers include easier volume comparisons, mid-single-digit production growth, and disciplined fixed-cost management; volume remains the main upside or downside variable.
Funeral volume outlook is flattish over the next 2-3 years; baby-boomer impact is expected to become more pronounced into the 2030s, with peak industry impact around the early 2040s.
Cemetery pre-need production has remained strong; annual production of $2.6B and a mid-single-digit growth algorithm indicate $100M-$125M of funeral and cemetery pre-need growth next year, absent a major consumer-sentiment decline.
Cemetery margin percentages are expected to expand 30-50 bps with mid-single-digit production growth; near-term funeral margins are expected to remain flat.
Industry and business mix
Large cemetery sales represent 11%-12% of roughly $1.4B in cemetery production; management expects low-to-mid-single-digit annual growth, while noting deal timing can make quarterly results lumpy.
Cremation mix has been increasing near 60 bps annually, within a 50-100 bps outlook; management expects the rate to slow as penetration approaches the 75%-80% levels seen in some other markets.
Cemetery pre-need sales showed no material consumer-economy impact in 2026; large-sale activity may be more sensitive to financial-market volatility.
Latest events from Service Corporation International
- Revenue and adjusted EPS rose, but volume and cost pressures lowered FY2026 guidance.SCI
Q3 2026 - Q2 2026 EPS rose to $0.90, revenue hit $1.10B, and preneed sales and cash flow were strong.SCI
Q2 2026 - Normalized volumes, margin gains, and digital initiatives drive steady growth and resilience.SCI
BofA Securities Leveraged Finance Conference 2025 - Q1 funeral volumes fell 6%, but preneed sales and cost controls support stable outlook.SCI
Bank of America Global Healthcare Conference 2026 - Strong pre-need sales and operational scale support robust margins and long-term growth.SCI
Oppenheimer 21st Annual Industrial Growth Virtual Conference - Q2 revenue up, adjusted EPS down; strong cash flow and guidance reaffirmed.SCI
Q2 2024 - Q3 2024 saw higher cash flow, stable margins, and strong acquisitions with a positive outlook.SCI
Q3 2024 - Stable funeral volumes, strong pre-need sales, and margin growth drive long-term EPS gains.SCI
25th Annual Consumer Growth and E-Commerce Conference - Q1 2025 delivered higher revenue and EPS, with strong funeral results and steady 2025 outlook.SCI
Q1 2025